Does Carnitine-Fatigue-Meta-Analysis work?

The current Migaku evidence database contains 1 reusable source document for Carnitine-Fatigue-Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove. - Mounting evidence highlights relevant metabolic dysregulation in PCS, with enduring disruptions in energy metabolism, amino acid metabolism, and lipid metabolism persisting for up to two years post-infection. [Oestreich Martin (2026); evidence level 4] - The aim of the current study was to compare soluble blood biomarkers of ED and amino acid, fatty acid, carnitine, eicosanoid and resolvin related metabolism in a well-characterized cohort of individuals with or without PCS at a median of 37.4 weeks post-acute infection and to investigate whether these biomarkers are associated with PCS-related fatigue severity. [Oestreich Martin (2026); evidence level 4] - The questionnaire includes five subscales: general fatigue, physical fatigue, reduced activity, reduced motivation and mental fatigue. [Oestreich Martin (2026); evidence level 4] - 1 According to the World Health Organization (WHO), the post-COVID-19 syndrome (PCS) is a condition characterized by symptoms that persist for at least three months following infection with SARS-CoV-2, last for more than two additional months, and cannot be attributed to any other underlying disease. [Oestreich Martin (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.